Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2019: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2018: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2017: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Outline of Final Research Achievements |
Poorly differentiated thyroid cancer is a disease with a poor prognosis and patients often have RAS-signaling abnormality. It has been suggested that polyoma virus infection might occur in the thyroid glands. The purpose of this study was to understand whether the RAS-signaling abnormality and polyoma virus infection work together in the development of thyroid cancer. We constructed a genetically engineered mouse (GEM) model that expresses an oncogenic Kras mutation and SV40 tsA58, which is derived from a polyoma virus, large T antigen (TAg) in the thyroids of the GEM model. Forced activation of Ras-signaling and TAg expression resulted in poorly differentiated thyroid cancer in the GEM model. These results suggest that RAS-signaling abnormalities and polyoma virus infection might work together in the development of thyroid cancer.
|